| Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen (NCT06127407) | Servier Bio-Innovation LLC | 2024-07-09 |
| Safety and Efficacy of Tocilizumab in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease (NCT06452537) | Tianjin Medical University General Hospital | 2024-07-09 |
| A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF) (NCT06024746) | Colorado Prevention Center | 2024-07-09 |
| NSAIDS Following Elective Lumbar Spine Fusion (NCT07743606) | Rothman Institute Orthopaedics | 2024-07-08 |
| A Study to Evaluate the Efficacy and Safety of Enlicitide (MK-0616, Oral PCSK9 Inhibitor) Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia (MK-0616-018/CORALreef AddOn) (NCT06450366) | Merck Sharp & Dohme LLC | 2024-07-08 |
| A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab (NCT06100744) | AbbVie | 2024-07-08 |
| Fixed Dose Combination of Desloratadine / Prednisolone in the Treatment of Moderate Severe Allergic Rhinitis in Children (NCT05214911) | Eurofarma Laboratorios S.A. | 2024-07-08 |
| Combination of Hypothermia and Thrombectomy in Acute Stroke (NCT06301412) | University of Freiburg | 2024-07-07 |
| A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease (NCT06248619) | Amgen | 2024-07-05 |
| Convalescent Plasma for the Treatment of Patients With WNV - a Double- Blind Randomized Controlled Study (NCT06590207) | Sheba Medical Center | 2024-07-04 |
| Short Versus Long-term Levetiracetam in Brain Tumors (NCT06442748) | Tata Memorial Centre | 2024-07-04 |
| ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer (NCT06498479) | Hansoh BioMedical R&D Company | 2024-07-04 |
| A Study to Evaluate the Efficacy and Safety of SIM0718 in Adult and Adolescent Patients With Moderate to Severe Atopic Dermatitis (NCT06477835) | Simcere Pharmaceutical Co., Ltd | 2024-07-04 |
| A Study of Lebrikizumab Treatment in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis (NCT06526182) | Almirall, S.A. | 2024-07-03 |
| Low Amplitude Pulse Seizure Therapy Versus Standard Ultra-Brief Right Unilateral Electroconvulsive Therapy (NCT06529029) | Michigan State University | 2024-07-03 |
| ctDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: A Single-center, Randomized, Controlled Study (NCT06609551) | Zhejiang Cancer Hospital | 2024-07-03 |
| Efficacy and Safety of Rexlemestrocel-L Combined With HA* in Participants With Moderate to Severe Chronic Low Back Pain (NCT06325566) | Mesoblast, Ltd. | 2024-07-03 |
| Continuation Protocol for Obstructive Sleep Apnea (OSA) (NCT06566820) | Apnimed | 2024-07-03 |
| RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis (NCT06328777) | Cabaletta Bio | 2024-07-02 |
| Different Medications to Induce Labor (NCT06259097) | Icahn School of Medicine at Mount Sinai | 2024-07-02 |
| A Study of TAK-861 for the Treatment of Narcolepsy Type 1 (NCT06470828) | Takeda | 2024-07-02 |
| A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Severe AADC Deficiency (NCT06432140) | Shanghai Vitalgen BioPharma Co., Ltd. | 2024-07-02 |
| Effectiveness of 3D Bone Matrix in Cranioplasty (NCT06792864) | Universidad Austral de Chile | 2024-07-01 |
| A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TB (NCT06526039) | Taipei Medical University WanFang Hospital | 2024-07-01 |
| VERIFY: Vedolizumab for the Prevention of Immune Checkpoint Inhibitor Related Diarrhea or Colitis in Patients With Cancer (NCT06337695) | University of Calgary | 2024-07-01 |
| Alkaline Water and Salivary Bacterial Count (NCT06511336) | Pharos University in Alexandria | 2024-07-01 |
| Effectiveness of 3D-printed Patient-specific Resorbable Scaffolds for Maxillary Bone Regeneration (NCT06773923) | Universidad Austral de Chile | 2024-07-01 |
| To Evaluate Safety and Tolerability of the Fixed- Dose Combination of Obeticholic Acid and Bezafibrate (NCT06488911) | Intercept Pharmaceuticals | 2024-07-01 |
| Evaluation of Liquorice Nanogel Versus Diode Laser as an Adjunctive Treatment for Patients With Periodontitis Stage Ⅲ. (NCT07602738) | Al-Azhar University | 2024-07-01 |
| Quelling of Excitotoxicity in Acute Stroke With Ketamine (NCT03223220) | Lower Merion Neurology Research Foundation | 2024-07-01 |
| Cocaine, Lidocaine/xylometazoline and Saline for Nasal Analgesia (NCT06443255) | Rigshospitalet, Denmark | 2024-07-01 |
| Deep Cervical Lymphatlc-Venous Anastomosis Surgery for the Treatment of Alzheimer's Disease: A Pilot Study (DIVA Study) (NCT06530732) | Zhejiang Provincial People's Hospital | 2024-07-01 |
| Efficacy and Safety of Toronto Association in the Treatment of Erectile Dysfunction and Premature Ejaculation (NCT05052879) | EMS | 2024-07-01 |
| Borderline of CME/D3 Dissection for Local Advanced Right-sided Colon Cancer (NCT06709144) | Haixing Ju, MD | 2024-07-01 |
| Toripalimab Plus Anlotinib for the Maintenance of Extensive Stage Small Cell (NCT06441344) | Taizhou Hospital | 2024-07-01 |
| In Patients With Chronic Liver Diseases(Alcoholic Liver Disease and Non-Alcoholic Fatty Liver Disease), LAENNEC(Human Placenta Hydrolysate) is to Evaluate the Efficacy and Safety of Intravenous Drop (NCT06493799) | Green Cross Wellbeing | 2024-07-01 |
| PFLL Combined With PD-1 Antibody With or Without FMT for Oligometastatic NPC,a Phase III ,Open, Randomized Clinical Trial. (NCT06486220) | Yun-fei Xia | 2024-07-01 |
| Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder (NCT06233799) | National Institute on Drug Abuse (NIDA) | 2024-07-01 |
| A Clinical Study of B007 in the Treatment of Generalized Myasthenia Gravis. (NCT06447597) | Shanghai Jiaolian Drug Research and Development Co., Ltd | 2024-07-01 |
| Safety and Efficacy of Botulinum Toxin-A Injection Into Ischiocavernosus Muscle for Premature Ejaculation (NCT06851598) | Abdallah Mohamed Abdallah Mohamed Elgendy | 2024-07-01 |
| Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer (NCT06475599) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-07-01 |
| Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age (NCT06380517) | Jaeb Center for Health Research | 2024-07-01 |
| Role of Colchicine as Anti-Inflammatory Therapy in HFpEF (NCT06837623) | Cairo University | 2024-07-01 |
| Comparison Between Effect of Empirical Antibiotic Prophylaxis Versus Enhanced Prophylactic Measures on Rate of Urinary Tract Infection After Flexible Ureteroscopy in Children With Pyuria (NCT07229755) | Ain Shams University | 2024-07-01 |
| Outcomes in Bone Marrow Aplasia. (NCT06493981) | Assiut University | 2024-07-01 |
| Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction II (NCT06271772) | University of California, San Francisco | 2024-07-01 |
| CMV-specific T Cell Immunity Test Indicated Prophylaxis of Letermovir After All-HSCT (NCT06449586) | Ruijin Hospital | 2024-07-01 |
| Segmentectomy for Solid-dominant Lung Cancer (NCT06634966) | Fudan University | 2024-07-01 |
| Parasitic Ulcer Treatment Trial (NCT06213649) | Jeremy Keenan, MD, MPH | 2024-07-01 |
| Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes (NCT06082063) | Steno Diabetes Center Copenhagen | 2024-07-01 |
| Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis (NCT06022939) | SWOG Cancer Research Network | 2024-07-01 |
| LIMIT Trial - Lidocaine With Intramuscular Injection of Benzathine Penicillin G for Treponema Pallidum Treatment (NCT06391125) | Washington University School of Medicine | 2024-07-01 |
| Aprepitant Plus Granisetron and Dexamethasone for the Prevention of Vomiting in Patients With HAIC Therapy for HCC (NCT05711823) | Guangxi Medical University | 2024-07-01 |
| DOSAGE Study: Upfront Dose-Reduced Chemotherapy in Older Patients with Metastatic Colorectal Cancer (NCT06275958) | Leiden University Medical Center | 2024-07-01 |
| A Multicenter, Prospective, Randomized, Controlled Study of Decitabine in Combination With R-CHOP for Initial Treatment of EBV+ Diffuse Large B-cell Lymphoma (NCT07348575) | Second Affiliated Hospital of Nanchang University | 2024-07-01 |
| Safety and Efficacy Study of Pilocarpine HCl Ophthalmic Solution in Participants With Presbyopia (NCT06451666) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2024-06-30 |
| SAINT for MDD in an Inpatient Setting Follow-on (NCT06462820) | Magnus Medical | 2024-06-30 |
| Myoinositol, L-arginine and Chromium With Letrozole for Ovulation Induction in Polycystic Ovarian Syndrome Patients (NCT06405243) | Beni-Suef University | 2024-06-30 |
| 7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication (NCT06576882) | Alexandria University | 2024-06-30 |
| The Effects of SAINT® Neuromodulation System on Explicit and Implicit Suicidal Cognition (NCT03693105) | Magnus Medical | 2024-06-30 |
| A Multicenter, Phase 3 Study of IBI343 Monotherapy Versus Treatment of Investigator's Choice in Subjects With Previously Treated, Claudin (CLDN) 18.2-positive, HER2-negative, Gastric or Gastroesophageal Junction Adenocarcinoma (G-HOPE-001) (NCT06238843) | Innovent Biologics (Suzhou) Co. Ltd. | 2024-06-30 |
| of Myo-inositol, Melatonin and Co-enzyme q10 on Ovarian Reserve (NCT06405204) | Beni-Suef University | 2024-06-30 |
| A Phase III Study to Investigate the Efficacy and Safety of Anifrolumab in Adults With Chronic and/or Subacute Cutaneous Lupus Erythematosus (NCT06015737) | AstraZeneca | 2024-06-29 |
| Comparison Study of SIBP's MMR Vaccine Versus GSK MMR Vaccine in Children Aged 9-11 Months (NCT06399003) | Shanghai Institute Of Biological Products | 2024-06-28 |
| A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis (NCT06392386) | argenx | 2024-06-28 |
| A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3) (NCT06263231) | Intensity Therapeutics, Inc. | 2024-06-28 |
| Trial to Visualize the Ureters With Nizaracianine Triflutate in Adults Undergoing Abdominopelvic Surgery (NCT06101745) | Curadel Surgical Innovations, Inc. | 2024-06-28 |
| Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR) (NCT06331312) | Novartis Pharmaceuticals | 2024-06-28 |
| Early Intravenous to Oral Antibiotic Switch in Uncomplicated Staphylococcus Aureus Bacteraemia (NCT06336824) | Clinical Research Centre, Malaysia | 2024-06-28 |
| Comparing Methylprednisolone And Hyaluronic Acid To Reduce Wisdom Tooth Surgery Complications (NCT07317596) | Sana'a University | 2024-06-27 |
| Luteal Phase Support With GnRH Agonist After GnRH Agonist Triggering in IVF/ICSI Cycles (NCT06150703) | Assistance Publique - Hôpitaux de Paris | 2024-06-27 |
| Brightline-3: A Study to Find Out Whether Brigimadlin in Combination With Ezabenlimab Helps People With Advanced Soft Tissue Sarcoma (NCT06370871) | Boehringer Ingelheim | 2024-06-27 |
| Efficacy of Solifenacin, Mirabegron and Combination Therapy in Children With Daytime Urinary Incontinence (BeDry) (NCT06551246) | University of Aarhus | 2024-06-27 |
| Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease (NCT05799378) | NYU Langone Health | 2024-06-27 |
| A Study to Assess Disease Activity and Safety of Lutikizumab in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa (NCT06468228) | AbbVie | 2024-06-27 |
| Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-302) (NCT06439602) | Arthrosi Therapeutics | 2024-06-26 |
| Randomized Phase III Trial Testing Maintenance Olaparib Versus Observation After Adjuvant Chemoradiation for p53abn Endometrial Cancer (NCT06712472) | Gustave Roussy, Cancer Campus, Grand Paris | 2024-06-26 |
| Comparison Partial Versus Total Omentectomy in Minimal Invasive Distal Gastrectomy for cT3/4a Gastric Cancer (KLASS-10) (NCT06608381) | Gangnam Severance Hospital | 2024-06-26 |
| A Study of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With Aticaprant (NCT06514742) | Janssen Research & Development, LLC | 2024-06-26 |
| Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer (NCT06205485) | Canadian Cancer Trials Group | 2024-06-26 |
| Evaluation of the Effectiveness of Hormonal Treatment in Adolescents Suffering From Gender Dysphoria (NCT06351501) | Assistance Publique - Hôpitaux de Paris | 2024-06-25 |
| Absorbed Tumor Dose in Peptide Receptor Radionuclide Therapy with Long-acting Somatostatin Analogues - ATSA Trial (NCT06855095) | The Netherlands Cancer Institute | 2024-06-25 |
| Efficacy and Safety of a New Formulation of Oral Cladribine Compared With Placebo in Participants With Generalized Myasthenia Gravis (MyClad) (NCT06463587) | Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany | 2024-06-25 |
| A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis (NCT06425549) | UCB Biopharma SRL | 2024-06-25 |
| ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack (NCT06118281) | Novo Nordisk A/S | 2024-06-25 |
| Study on the Treatment of Prurigo Nodularis With Stapokibart Injection (NCT06424470) | Keymed Biosciences Co.Ltd | 2024-06-25 |
| Study of Intravenous TAD® 600 Mg/4 ML Solution for Injection to Evaluate Efficacy and Safety in Preventing Myocardial Injury in Patients with Pneumonia. (NCT06296212) | Biomedica Foscama S.p.A. Industria Chimico-Farmaceutica | 2024-06-25 |
| A Phase 3 Study to Evaluate Petosemtamab Compared With Investigator's Choice Monotherapy in Previously Treated Head and Neck Squamous Cell Carcinoma Patients (LiGeR-HN2) (NCT06496178) | Merus B.V. | 2024-06-25 |
| Adjuvant vs Surgery Only in Early-stage Recurrent NPC (NCT06228079) | Eye & ENT Hospital of Fudan University | 2024-06-25 |
| LM-302 for the Treatment of Subjects With Claudin18.2-Positive Gastric and Gastroesophageal Junction Adenocarcinoma. (NCT06351020) | LaNova Medicines Zhejiang Co., Ltd. | 2024-06-24 |
| Evaluate the Neurological Effects of EryDex on Subjects With A-T (NCT06193200) | Quince Therapeutics S.p.A. | 2024-06-24 |
| Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial (NCT06203600) | National Cancer Institute (NCI) | 2024-06-24 |
| Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012) (NCT06393374) | Merck Sharp & Dohme LLC | 2024-06-24 |
| The Medically Reproducing Bariatric Surgery (MRB) II Study (NCT06363747) | Durham VA Medical Center | 2024-06-24 |
| ESCALATion of Medical Therapy Following Multimodality Plaque Evaluation in High-risk Chronic Coronary Syndromes (NCT06469528) | King's College Hospital NHS Trust | 2024-06-24 |
| A Study to Assess Safety, Tolerability and Immunogenicity of RSVpreF From Multidose Vials in Healthy Female Adults. (NCT06473519) | Pfizer | 2024-06-24 |
| A Trial to Assess the Safety and Efficacy of Subjects With Dry Eye Disease (NCT06493604) | Aldeyra Therapeutics, Inc. | 2024-06-24 |
| Efficacy and Safety Study of 610 in Patients With Severe Asthma (NCT06323213) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2024-06-24 |
| Precision Ventilation vs Standard Care for Acute Respiratory Distress Syndrome (NCT06066502) | Beth Israel Deaconess Medical Center | 2024-06-24 |
| A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101) (NCT06585696) | Cutia Therapeutics（Wuxi）Co.,Ltd | 2024-06-24 |